-+ 0.00%
-+ 0.00%
-+ 0.00%

United Therapeutics Chairperson, CEO Martine Rothblatt disposes of 9,500 common shares for $5.01 million

PUBT·08/20/2026 20:37:51
Listen to the news
United Therapeutics Chairperson, CEO Martine Rothblatt disposes of 9,500 common shares for $5.01 million
  • United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised 9,500 stock options at USD 135.42 on Aug. 19, 2026.
  • The trust sold 9,500 shares the same day across multiple trades at about USD 522.49 to USD 535.22.
  • Trust holdings ended at 324,443 shares following the transactions, according to the filing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000124), on August 20, 2026, and is solely responsible for the information contained therein.